Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Quarterly Statistics: Q3 Financings Slump Despite Large Gossamer Series B, Big Rubius IPO

Executive Summary

Third quarter biopharma start-up financing activity decreased from the record-breaking Q2. A review of biopharma start-up dealmaking and financing activity from July through September 2018, based on data from Strategic Transactions.

Advertisement

Related Content

Just What We Were Looking For: Roche Pays €70m For Preclinical Anti-CD25 Asset
Allergan Buys Bonti, Releases New Data In Defense Of 'Iconic' Botox Brand
Deal Watch: Emergent Strikes Again, Acquiring Adapt And Its Opioid Overdose Drug For $635m
Bluebird Casts Wide Partnering Net To Keep Advancing Cell Therapy
Deal Watch: Harbour Expands Horizons Beyond China
Orchard Raises Another $150m For Gene Therapy Pot
Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year
Deal Watch: Gilead Continues To Add To IO Armamentarium In Collaboration With Gadeta
Roivant Splashes Cash Again To License GSK Skin Disorder Drug
Axovant Hopes Gene Silence Is Golden With Benitec Pact

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC124055

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel